{"id":"W2961683851","doi":"10.1016/s2213-8587(19)30084-1","title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":1508,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Queen's University","funders":"Novo Nordisk; California Walnut Commission; Eli Lilly and Company; Université Laval; International Atherosclerosis Society; AstraZeneca; International Chair on Cardiometabolic Risk; Amgen","keywords":"Medicine; Obesity; Disease; Epidemiology; Diabetes mellitus; Adipose tissue; Metabolic syndrome; Public health; Internal medicine; Intensive care medicine; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}